Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Genetic toxicity: in vivo

Currently viewing:

Administrative data

Endpoint:
in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
Remarks:
Type of genotoxicity: chromosome aberration
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Basic data given: scientifically acceptable study summary including result tables; the test protocol can be viewed online.

Data source

Reference
Reference Type:
publication
Title:
Unnamed
Year:
1989

Materials and methods

Principles of method if other than guideline:
According to the NTP standard protocols
GLP compliance:
no
Type of assay:
micronucleus assay

Test material

Constituent 1
Chemical structure
Reference substance name:
Allyl 2,3-epoxypropyl ether
EC Number:
203-442-4
EC Name:
Allyl 2,3-epoxypropyl ether
Cas Number:
106-92-3
Molecular formula:
C6H10O2
IUPAC Name:
2-[(prop-2-en-1-yloxy)methyl]oxirane
Details on test material:
- Name of test material (as cited in study report): Allyl glycidyl ether

Test animals

Species:
mouse
Strain:
not specified
Sex:
male

Administration / exposure

Route of administration:
intraperitoneal
Vehicle:
- Vehicle(s)/solvent(s) used: physiol. saline
Frequency of treatment:
3, administered at 24 hr intervals
Doses / concentrations
Remarks:
Doses / Concentrations:
50, 100 and 200 mg/kg bw
Basis:

No. of animals per sex per dose:
3-5 (3 males were used in trial 1 at dose level of 200 mg/kg bw; in the 2nd trial, 5, 4 and 5 mice were used at dose levels of 50, 100 and 200 mg/kg bw, respectively)
Control animals:
yes, concurrent vehicle
Positive control(s):
mitomycin C
- Doses / concentrations: 0.2 mg/kg bw

Examinations

Tissues and cell types examined:
bone marrow
Details of tissue and slide preparation:
TREATMENT AND SAMPLING TIMES: harvesting of the bone marrow done at 24 hours after the last dosing.

DETAILS OF SLIDE PREPARATION: The animals are euthanized by CO2 inhalation and the femurs are removed. The bone marrow is flushed from the femurs and spread onto slides. The slides are air-dried, fixed, and stained with a fluorescent DNA-specific stain that easily illuminates any micronuclei that may be present. Typically, 2000 polychromatic erythrocytes (PCEs, reticulocytes; immature erythrocytes) are scored per animal for frequency of micronucleated cells in each of 3-5 animals per dose group.

Results and discussion

Test results
Sex:
male
Genotoxicity:
positive
Toxicity:
not specified
Vehicle controls validity:
valid
Positive controls validity:
valid

Any other information on results incl. tables

     Trial 1:

 

Dose (mg/kg)

Number of Animals Scored

Mean MN-PCE/1000 PCE ± SEM

Pairwise P

Phosphate Buffered Saline

 0         

3

1.67 ± 1.20

 

Allyl glycidyl ether

200         

3

14.67 ± 2.03

< 0.0001

Mitomycin-C

 0.2       

2

10.50 ± 3.50

*

    * Insufficient animals scored to calculate p-value.

   

    Trial 2:

 

Dose (mg/kg)

Number of Animals Scored

Mean MN-PCE/1000 PCE ± SEM

Pairwise P

Phosphate Buffered Saline

0

3

1.67 ± 1.20

 

 

Allyl glycidyl ether

50

5

4.40 ± 0.43

0.001

100

4

5.88 ± 0.90

< 0.0001

200

5

20.00 ± 2.01

< 0.0001

Mitomycin-C

0.2

5

6.50 ± 0.42

< 0.0001

 

Applicant's summary and conclusion